PrEP: latest news

PrEP resources

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • What Preventing HIV in Babies Can Tell Us about Preventing HIV in Adults

    Between 1991 and 2010, a massively successful public health strategy reduced the number of babies born in the U.S. with HIV from over 1500 in a year to just over 150. Those engaged in the fight against HIV should look to and learn from the successes and experiences of perinatal HIV transmission prevention efforts.

    29 June 2015 | BETA blog
  • Pride in London: NHS to come under pressure to provide 'miracle' HIV prevention pill

    Campaigners from the Terrence Higgins Trust will carry placards calling on the Government to have pre-exposure prophylaxis (PrEP) made freely available on the NHS as an HIV prevention strategy for gay men.

    27 June 2015 | The Independent
  • Toward Comprehensive HIV Prevention Service Delivery in the United States: An Action Plan

    This action plan, based primarily on the proceedings of the two consultations, seeks to define a communityfocused national strategy for integrating historically separate HIV prevention interventions and services— many with established positive effects on individual health outcomes—into needs-driven components of population-based care and support programs.

    25 June 2015 | Treatment Action Group
  • A Message from AIDS Healthcare Foundation on PrEP and the IAS

    AIDS Healthcare Foundation (AHF)'s position on PrEP is habitually misrepresented. This trend hit a new low recently when Chris Beyrer, International AIDS Society (IAS) president, publicly accused AHF of “PrEP denialism” in a plenary session at the South Africa AIDS Conference (SAAC).

    24 June 2015 | AIDS Healthcare Foundation
  • HIV prevention pill test begins in Amsterdam gay, transgender community

    The study will focus on the interest to use PrEP, compliance on taking the pill, how it is to use Prep and whether the cost of this program outweigh the costs saved by preventing people from becoming infected with HIV.

    23 June 2015 | NL Times
  • PrEP data links anti-HIV immune response to reduce chance of infection

    "The rigor of the placebo-controlled iPrEx trial gave us access to the necessary data and specimens to address that question. What we found was what people have been looking for, for a long time - a correlation between future infection risk and a measureable immune response."

    23 June 2015 | Medical Xpress
  • Two AIDS Organizations Publicly Battle Over PrEP

    A new pro-PrEP ad campaign by the AIDS Foundation of Chicago launched today in response to an advertorial campaign across LGBT media outlets by AIDS Healthcare Foundation that prompted the community to consider the consequences of widespread PrEP use, calling it a “War on Prevention.”

    22 June 2015 | HIV Plus
  • Delivering effective HIV Prevention in the UK: time to venture into new territories

    Fragmented and rarely aligned with local needs (as noted in a 2015 National AIDS Trust report on HIV Prevention in England), the emphasis on delivering primary prevention fails to address the multidimensional nature of the epidemic and the structural factors that foster it. It also a fails to acknowledge and incorporate the scientific achievements of the recent years in HIV prevention into service delivery.

    22 June 2015 | Incidence 0
  • PrEP is not linked to greater risk for depression

    A new paper out of the iPrEx study--a randomized, placebo-controlled trial of daily oral HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men -- reported no link between taking Truvada for oral PrEP and experiencing depression.

    22 June 2015 | Eurekalert Medicine & Health
  • Australia’s Long Wait for Truvada

    At last year's Melbourne AIDS conference, every state and federal health minister in Australia pledged to eliminate HIV transmissions by 2020. While there's been a suite of measures set in place to achieve this, there's one thing missing: and that's widespread access to PrEP (or Pre-Exposure Prophylaxis), facilitated with a drug called Truvada.

    19 June 2015 | Vice
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.